Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia

NCT00077012 is registered in ClinicalTrials.gov with QLT Inc. as lead sponsor.

NCT NCT00077012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00077012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia
Lead sponsor
QLT Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2003
Completion date
May 31, 2005
Enrollment
Not reported
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia